Clinical Trial

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Study acronym: IPMR ASD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 14, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-17; most recent amendment 2025-10-10.
Status change: Not Yet Recruiting → Recruiting 2023-11-09
Trial Details
NCT Number NCT06006637
Lead Sponsor State University of New York - Upstate Medical University
Collaborators: JelikaLite LLC, Mt. Sinai School of Medicine, New York, New York, MetroEHS
Conditions Autism Spectrum Disorder
Enrollment 80 participants
Start Date 2023-10-17
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2025-10-14